Assess Measurements of Wireless Cardiac Output Device

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

25 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-09-30

Study Completion Date

2014-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Heart failure is a common cardiovascular problem which is increasing in both prevalence and incidence and associated with substantial morbidity and mortality. The management of heart failure patients is complex and has become a priority world over. Effective methods to keep heart failure patients out of the hospital are essential, both in the interests of the patient's health, as well as to reduce the burden on the health care system

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Necklace-Shaped Sensor for Non-Invasive Remote Monitoring of Vitals

NCT02337790

Heart Failure Hypertension

COMPLETED

Remotely Monitoring Patients With Chronic Conditions in Their Home

NCT03207802

CHF

COMPLETED

Study on Cardiac Output Evaluation Based on Wearable Monitoring Data

NCT06938893

Cardiac Output

NOT_YET_RECRUITING

Validation of a Sensor for Non-invasive Measurement of Stroke Volume and Cardiac Output

NCT04255108

Cardiac Failure

COMPLETED

Pilot Study of the CoVa™ Monitoring of Patients With Congestive Heart Failure

NCT02368184

Congestive Heart Failure

WITHDRAWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Heart failure patients should be in a position to provide readings of their weight, blood pressure, fluid intake, thoracic fluid, heart rate, heart rate variability, respiration rate, stroke volume, cardiac output, medications and other important parameters and communicate this data to care providers using wireless technology. This data should be made available to medical personnel regularly and on a periodic basis. In this manner the health care providers can detect and respond to warning signs or alerts before the patient's condition worsens to warrant a visit to the doctor or a hospital admission with features of heart failure decompensation. Programs for chronic heart failure that include remote monitoring have been shown to have a positive effect on clinical outcomes in community dwelling patients with chronic heart failure.

In preparation for a study evaluating the effectiveness of mobile monitoring, the value of Stroke Volume and Cardiac Output need to be validated against FDA approved devices that are available in a hospital or clinic setting. This study covers the validation of the measurements taken with the proposed home monitoring device, Perminova's CoVaTM Sensor (Sensor) against clinic devices such as bio-impedance devices, echocardiogram, Doppler and/or MRI

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Congestive Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CoVa

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Vitalbeat Remote Disease Managment

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects of either gender above the age of 18 years
* The subject is able and willing to provide written informed consent prior to enrollment in the study
* One or more of the following diagnosis
* New York Heart Association (NYHA) classification class of I-IV or Stages A-D
* Symptoms of dyspnea
* Chronic renal failure on renal replacement therapy

Exclusion Criteria

* Patients who may not come for follow up or likely to drop out of the study
* Any illness which may preclude regular follow up
* Patient is unable or not willing to wear electrode patches as required
* Patient has skin sensitivity to adhesive or hydrogel materials used in electrode patches
* Patient is considered by the PI to be medically unsuitable for study participation

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No